47.60
-0.80
(-1.65%)
At close: April 17 at 8:03:52 AM GMT+2
Research Analysis
Earnings Estimate
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | -- | -- | -- | -- |
Avg. Estimate | 0 | 0 | 0 | 0 |
Low Estimate | 0 | 0 | 0 | 0 |
High Estimate | 0 | 0 | 0 | 0 |
Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | 4 | 4 | 4 | 4 |
Avg. Estimate | 310.44M | 315.65M | 1.26B | 1.32B |
Low Estimate | 305.06M | 312.3M | 1.25B | 1.3B |
High Estimate | 316.59M | 321.12M | 1.27B | 1.34B |
Year Ago Sales | 298.36M | 312.94M | 1.24B | 1.26B |
Sales Growth (year/est) | 4.05% | 0.87% | 1.78% | 4.55% |
EPS Trend
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Current Estimate | 0 | 0 | 0 | 0 |
7 Days Ago | 0 | 0 | 0 | 0 |
30 Days Ago | 0 | 0 | 0 | 0 |
60 Days Ago | 0 | 0 | 0 | 0 |
90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | -- | -- | -- | -- |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
Current Qtr. | Next Qtr. | Current Year | Next Year | |
---|---|---|---|---|
EG0.F | -- | -- | -- | -- |
S&P 500 | 6.92% | 4.87% | 8.58% | 14.16% |
Upgrades & Downgrades
Maintains | Keefe, Bruyette & Woods: Outperform to Outperform | 4/8/2025 |
Upgrade | JP Morgan: Neutral to Overweight | 4/8/2025 |
Reiterates | RBC Capital: Outperform to Outperform | 2/18/2025 |
Maintains | Keefe, Bruyette & Woods: Outperform to Outperform | 2/18/2025 |
Maintains | Keefe, Bruyette & Woods: Outperform to Outperform | 1/8/2025 |
Downgrade | Barclays: Overweight to Equal-Weight | 1/6/2025 |